Steve Harr - 02 Mar 2023 Form 4 Insider Report for Sana Biotechnology, Inc. (SANA)

Role
President & CEO, Director
Signature
/s/ Bernard J. Cassidy, Attorney-in-Fact for Steve Harr
Issuer symbol
SANA
Transactions as of
02 Mar 2023
Net transactions value
$0
Form type
4
Filing time
03 Mar 2023, 15:35:50 UTC
Previous filing
08 Mar 2022
Next filing
08 Mar 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SANA Stock Options (Right to Buy) Award $0 +650,000 $0.000000 650,000 02 Mar 2023 Common Stock 650,000 $3.76 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable as to 25% of the underlying shares on March 2, 2024 and in 36 equal monthly installments thereafter.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney